Bleehen NM - Search Results

1

Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer.

Kerr DJ, Rustin GJ, Kaye SB, Selby P, Bleehen NM, Harper P, Brampton MH. Kerr DJ, et al. Among authors: bleehen nm. Br J Cancer. 1995 Nov;72(5):1267-9. doi: 10.1038/bjc.1995.498. Br J Cancer. 1995. PMID: 7577480 Free PMC article. Clinical Trial.

2

Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma.

Kerr DJ, Maughan T, Newlands E, Rustin G, Bleehen NM, Lewis C, Kaye SB. Kerr DJ, et al. Among authors: bleehen nm. Br J Cancer. 1989 Jul;60(1):104-6. doi: 10.1038/bjc.1989.230. Br J Cancer. 1989. PMID: 2803908 Free PMC article.

3

A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanoma.

Bleehen NM, Calvert AH, Lee SM, Harper P, Kaye SB, Judson I, Brampton M. Bleehen NM, et al. Br J Cancer. 1994 Oct;70(4):775-7. doi: 10.1038/bjc.1994.395. Br J Cancer. 1994. PMID: 7917939 Free PMC article. Clinical Trial.

4

O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.

Middleton MR, Lunn JM, Morris C, Rustin G, Wedge SR, Brampton MH, Lind MJ, Lee SM, Newell DR, Bleehen NM, Newlands ES, Calvert AH, Margison GP, Thatcher N. Middleton MR, et al. Among authors: bleehen nm. Br J Cancer. 1998 Nov;78(9):1199-202. doi: 10.1038/bjc.1998.654. Br J Cancer. 1998. PMID: 9820180 Free PMC article. Clinical Trial.

5

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P, Brampton MH. Bower M, et al. Among authors: bleehen nm. Cancer Chemother Pharmacol. 1997;40(6):484-8. doi: 10.1007/s002800050691. Cancer Chemother Pharmacol. 1997. PMID: 9332462 Clinical Trial.

6

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

Bleehen NM, Newlands ES, Lee SM, Thatcher N, Selby P, Calvert AH, Rustin GJ, Brampton M, Stevens MF. Bleehen NM, et al. J Clin Oncol. 1995 Apr;13(4):910-3. doi: 10.1200/JCO.1995.13.4.910. J Clin Oncol. 1995. PMID: 7707118 Clinical Trial.

7

Phase I study of intravenous 4-hydroxyanisole.

Rustin GJ, Stratford MR, Lamont A, Bleehen N, Philip PA, Howells N, Watfa RR, Slack JA. Rustin GJ, et al. Eur J Cancer. 1992;28A(8-9):1362-4. doi: 10.1016/0959-8049(92)90520-c. Eur J Cancer. 1992. PMID: 1515252 Clinical Trial.

8

Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer.

Boote DJ, Dennis IF, Twentyman PR, Osborne RJ, Laburte C, Hensel S, Smyth JF, Brampton MH, Bleehen NM. Boote DJ, et al. Among authors: bleehen nm. J Clin Oncol. 1996 Feb;14(2):610-8. doi: 10.1200/JCO.1996.14.2.610. J Clin Oncol. 1996. PMID: 8636778 Clinical Trial.

9

Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II. CRC Phase I/II Committee.

Twelves CJ, Gardner C, Flavin A, Sludden J, Dennis I, de Bono J, Beale P, Vasey P, Hutchison C, Macham MA, Rodriguez A, Judson I, Bleehen NM. Twelves CJ, et al. Among authors: bleehen nm. Br J Cancer. 1999 Aug;80(11):1786-91. doi: 10.1038/sj.bjc.6690598. Br J Cancer. 1999. PMID: 10468297 Free PMC article. Clinical Trial.

10

A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.

Bleehen NM, Newman HV, Rampling RP, Ramsay JR, Roberts JT, Bedford P, Nethersell AB. Bleehen NM, et al. Br J Cancer. 1995 Sep;72(3):766-8. doi: 10.1038/bjc.1995.407. Br J Cancer. 1995. PMID: 7669591 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters